Telomir Pharmaceuticals
TELO
#8541
Rank
A$0.22 B
Marketcap
$7.57
Share price
-9.07%
Change (1 day)
N/A
Change (1 year)

EPS for Telomir Pharmaceuticals (TELO)

EPS in 2023 (TTM): -$0.18

According to Telomir Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.04634 a decrease over its 2021 EPS that were of -$0.007494.

EPS history for Telomir Pharmaceuticals from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.18298.28%
2022-$0.04634518.37%
2021-$0.007494